Increased rates of NICU admission, preterm birth, eclampsia and additional adverse outcomes were shown for mothers with this allergy label and their infants
MILWAUKEE, Feb. 21, 2026 /PRNewswire/ — A non-narcotic analgesics allergy label (NNAAL) is associated with several adverse perinatal outcomes, indicating a need for additional maternal evaluation, according to new research being presented at the 2026 AAAAI Annual Meeting.
“There is a paucity of information regarding the effect of a non-narcotic analgesics allergy label on maternal and fetal outcomes,” said lead author Chang Su, MD. “Our study showed that having such a label can be associated with various adverse maternal and fetal outcomes. These findings are potentially practice-expanding because…